Browse by Authors and Editors

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 3.

Article

Backen, Alison C. and Lopes, Andre and Wasan, Harpreet and Palmer, Daniel H. and Duggan, Marian and Cunningham, David and Anthoney, Alan and Corrie, Pippa G. and Madhusudan, Srinivasan and Maraveyas, Anthony and Ross, Paul J. and Waters, Justin S. and Steward, William P. and Rees, Charlotte and McNamara, Mairéad G. and Beare, Sandy and Bridgewater, John A. and Dive, Caroline and Valle, Juan W. (2018) Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. British Journal of Cancer . ISSN 0007-0920

Valle, Juan W. and Wasan, Harpreet and Lopes, Andre and Backen, Alison C. and Palmer, Daniel H. and Morris, Karen and Duggan, Marian and Cunningham, David and Anthoney, D. Alan and Corrie, Pippa and Srinivasan, Narayanan and Maraveyas, Anthony and Ross, Paul J. and Waters, Justin S. and Steward, Will P. and Rees, Charlotte and Beare, Sandy and Dive, Caroline and Bridgewater, John A. (2015) Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. Lancet Oncology, 16 (8). pp. 967-978. ISSN 1474-5488

Ford, Hugo and Marshall, Andrea and Bridgewater, John A. and Janowitz, Tobias and Coxon, Fareeda and Wadsley, Jonathan and Mansoor, Wasat and Fyfe, David and Madhusudan, Srinivasan and Middleton, Gary and Swinson, Daniel and Falk, Stephen and Chau, Ian and Cunningham, David and Kareclas, Paula and Cook, Natalie and Blazeby, Jane M. and Dunn, Janet A. (2014) Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. Lancet Oncology, 15 (1). pp. 78-86. ISSN 1474-5488

This list was generated on Sat Feb 27 00:50:45 2021 UTC.